Function_NN
and_CC
activation_NN
of_IN
NF-kappa_NN
B_NN
in_IN
the_DT
immune_JJ
system_NN
._.

NF-kappa_NN
B_NN
is_VBZ
a_DT
ubiquitous_JJ
transcription_NN
factor_NN
._.

Nevertheless_RB
,_,
its_PRP$
properties_NNS
seem_VBP
to_TO
be_VB
most_RBS
extensively_RB
exploited_VBN
in_IN
cells_NNS
of_IN
the_DT
immune_JJ
system_NN
._.

Among_IN
these_DT
properties_NNS
are_VBP
NF-kappa_NN
B_NN
's_POS
rapid_JJ
posttranslational_JJ
activation_NN
in_IN
response_NN
to_TO
many_JJ
pathogenic_JJ
signals_NNS
,_,
its_PRP$
direct_JJ
participation_NN
in_IN
cytoplasmic\/nuclear_JJ
signaling_NN
,_,
and_CC
its_PRP$
potency_NN
to_TO
activate_VB
transcription_NN
of_IN
a_DT
great_JJ
variety_NN
of_IN
genes_NNS
encoding_VBG
immunologically_RB
relevant_JJ
proteins_NNS
._.

In_IN
vertebrates_NNS
,_,
five_CD
distinct_JJ
DNA_NN
binding_NN
subunits_NNS
are_VBP
currently_RB
known_VBN
which_WDT
might_MD
extensively_RB
heterodimerize_VB
,_,
thereby_RB
forming_VBG
complexes_NNS
with_IN
distinct_JJ
transcriptional_JJ
activity_NN
,_,
DNA_NN
sequence_NN
specificity_NN
,_,
and_CC
cell_NN
type_NN
-_:
and_CC
cell_NN
stage_NN
-_TO
specific_JJ
distribution_NN
._.

The_DT
activity_NN
of_IN
DNA_NN
binding_NN
NF-kappa_NN
B_NN
dimers_NNS
is_VBZ
tightly_RB
controlled_VBN
by_IN
accessory_JJ
proteins_NNS
called_VBN
I_CD
kappa_NN
B_NN
subunits_NNS
of_IN
which_WDT
there_EX
are_VBP
also_RB
five_CD
different_JJ
species_NNS
currently_RB
known_VBN
in_IN
vertebrates_NNS
._.

I_NN
kappa_NN
B_NN
proteins_NNS
inhibit_VBP
DNA_NN
binding_NN
and_CC
prevent_VBP
nuclear_JJ
uptake_NN
of_IN
NF-kappa_NN
B_NN
complexes_NNS
._.

An_DT
exception_NN
is_VBZ
the_DT
Bcl-3_NN
protein_NN
which_WDT
in_IN
addition_NN
can_MD
function_VB
as_IN
a_DT
transcription_NN
activating_VBG
subunit_NN
in_IN
th_DT
nucleus_NN
._.

Other_JJ
I_NN
kappa_NN
B_NN
proteins_NNS
are_VBP
rather_RB
involved_VBN
in_IN
terminating_VBG
NF-kappa_NN
B_NN
's_POS
activity_NN
in_IN
the_DT
nucleus_NN
._.

The_DT
intracellular_JJ
events_NNS
that_WDT
lead_VBP
to_TO
the_DT
inactivation_NN
of_IN
I_NN
kappa_NN
B_NN
,_,
i.e._FW
the_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
,_,
are_VBP
complex_JJ
._.

They_PRP
involve_VBP
phosphorylation_NN
and_CC
proteolytic_JJ
reactions_NNS
and_CC
seem_VBP
to_TO
be_VB
controlled_VBN
by_IN
the_DT
cells_NNS
'_POS
redox_NN
status_NN
._.

Interference_NN
with_IN
the_DT
activation_NN
or_CC
activity_NN
of_IN
NF-kappa_NN
B_NN
may_MD
be_VB
beneficial_JJ
in_IN
suppressing_VBG
toxic\/septic_JJ
shock_NN
,_,
graft-vs-host_JJ
reactions_NNS
,_,
acute_JJ
inflammatory_JJ
reactions_NNS
,_,
acute_JJ
phase_NN
response_NN
,_,
and_CC
radiation_NN
damage_NN
._.

The_DT
inhibition_NN
of_IN
NF-kappa_NN
B_NN
activation_NN
by_IN
antioxidants_NNS
and_CC
specific_JJ
protease_NN
inhibitors_NNS
may_MD
provide_VB
a_DT
pharmacological_JJ
basis_NN
for_IN
interfering_VBG
with_IN
these_DT
acute_JJ
processes_NNS
._.

